Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Upstream-binding factor 1-like protein 1 (UBTFL1) is a transcription factor predicted to enable specific DNA binding and general transcription initiation activity with RNA polymerase I[1][3]. It is essential for the proliferation of the inner cell mass and trophectodermal cells during peri-implantation development[2][6][7]. UBTFL1 is primarily active in the nucleus and is involved in the regulation of gene expression, blastocyst growth, and embryo implantation[1][2]. There is currently no evidence that UBTFL1 is a direct therapeutic target, is associated with small-molecule drugs, or acts as a disease biomarker[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upstream-binding factor 1-like protein 1 (UBTFL1).